Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Cater

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
ACS Chemical Biology|May 10, 2013
Increasing intracellular bioavailable copper selectively targets prostate cancer cellsMichael A Cater, Helen B Pearson, Kamil Wolyniec, et al.
Oncotarget|May 14, 2016
Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distributionDelphine Denoyer, Helen B Pearson, Sharnel A S Clatworthy, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2011
An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copperIIPaul S Donnelly, Jeffrey R Liddell, SinChun Lim, et al.
The Journal of Biological Chemistry|June 23, 2010
Role of glutaredoxin1 and glutathione in regulating the activity of the copper-transporting P-type ATPases, ATP7A and ATP7BWilliam C J Singleton, Kelly T McInnes, Michael A Cater, et al.
Cell|September 7, 2010
Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's diseaseJames A Duce, Andrew Tsatsanis, Michael A Cater, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
ACS Chemical Biology|May 10, 2013
Increasing intracellular bioavailable copper selectively targets prostate cancer cellsMichael A Cater, Helen B Pearson, Kamil Wolyniec, et al.
Oncotarget|May 14, 2016
Copper as a target for prostate cancer therapeutics: copper-ionophore pharmacology and altering systemic copper distributionDelphine Denoyer, Helen B Pearson, Sharnel A S Clatworthy, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2011
An impaired mitochondrial electron transport chain increases retention of the hypoxia imaging agent diacetylbis(4-methylthiosemicarbazonato)copperIIPaul S Donnelly, Jeffrey R Liddell, SinChun Lim, et al.
The Journal of Biological Chemistry|June 23, 2010
Role of glutaredoxin1 and glutathione in regulating the activity of the copper-transporting P-type ATPases, ATP7A and ATP7BWilliam C J Singleton, Kelly T McInnes, Michael A Cater, et al.
Cell|September 7, 2010
Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's diseaseJames A Duce, Andrew Tsatsanis, Michael A Cater, et al.
Pageof 3